Salar Roshan

Salar Roshan is a corporate development executive with more than 17 years of experience in oncology and rare disease across small, medium, and large biopharmaceutical companies. He was formerly the vice president and head of corporate development at Rain Therapeutics, where he was responsible for Rain’s corporate and business development strategy. Prior to Rain, Salar served as the senior director of business development and licensing at MorphoSys and was a key member of the business development team that led the acquisition of Constellation Pharmaceuticals. Prior to MorphoSys, Salar was the vice president of business development & transactions at Anchiano Therapeutics. He has also held roles of increasing responsibility at Curis, Baxalta, Baxter Biosciences, Ironwood Pharmaceuticals, Takeda, Millennium Pharmaceuticals, and Genzyme.